Innovation Ignited: Unleashing the Power of Collaboration

Wilson Sonsini Presentation: Mastering IP Diligence for VC Investments and BioPharma Partnering

To make informed investment decisions and assess the risks and opportunities effectively, life science venture capitalists and biopharma must conduct thorough IP diligence when evaluating potential opportunities in this space. We’ll cover IP due diligence, patents, freedom-to-operate, IP licensing and IP litigation so a company can confidently present its IP assets to VCs and biopharma.

To read the full event description, and agenda visit the event website to register and learn more.